"Autoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
| Descriptor ID |
D001323
|
| MeSH Number(s) |
D12.776.124.486.485.114.323 D12.776.124.790.651.114.323 D12.776.377.715.548.114.323
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Autoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Autoantibodies".
This graph shows the total number of publications written about "Autoantibodies" by people in this website by year, and whether "Autoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 1 | 3 |
| 1996 | 2 | 4 | 6 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 1 | 4 |
| 2000 | 1 | 1 | 2 |
| 2001 | 4 | 2 | 6 |
| 2002 | 4 | 2 | 6 |
| 2003 | 4 | 4 | 8 |
| 2004 | 4 | 3 | 7 |
| 2005 | 2 | 2 | 4 |
| 2006 | 3 | 3 | 6 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 4 | 6 |
| 2009 | 1 | 4 | 5 |
| 2010 | 5 | 3 | 8 |
| 2011 | 5 | 7 | 12 |
| 2012 | 3 | 5 | 8 |
| 2013 | 0 | 3 | 3 |
| 2014 | 2 | 1 | 3 |
| 2015 | 2 | 5 | 7 |
| 2016 | 3 | 3 | 6 |
| 2017 | 1 | 4 | 5 |
| 2018 | 1 | 3 | 4 |
| 2019 | 6 | 2 | 8 |
| 2020 | 3 | 3 | 6 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 6 | 6 |
| 2023 | 0 | 5 | 5 |
| 2024 | 1 | 5 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project. Arthritis Rheumatol. 2025 Apr; 77(4):477-489.
-
Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negative. Lancet Psychiatry. 2024 10; 11(10):828-838.
-
Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC. Immunohorizons. 2024 08 01; 8(8):577-585.
-
A novel mechanism of idiopathic orthostatic hypotension and hypocatecholaminemia due to autoimmunity against aromatic l-Amino acid decarboxylase. Biochem Biophys Res Commun. 2024 06 25; 714:149940.
-
Longitudinal Assessment of Pancreas Volume by MRI Predicts Progression to Stage 3 Type 1 Diabetes. Diabetes Care. 2024 Mar 01; 47(3):393-400.
-
Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals. Front Immunol. 2024; 15:1348041.
-
Hope or hype? Clinicians' dilemma in the era of ever-expanding antigens in membranous nephropathy. Nephrol Dial Transplant. 2023 Nov 30; 38(12):2666-2669.
-
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans. Cancer Res Commun. 2023 11 08; 3(11):2256-2267.
-
Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events. Oncologist. 2023 05 08; 28(5):440-448.
-
[The Black Death, natural selection and susceptibility to auto-immune disorders]. Med Sci (Paris). 2023 04; 39(4):331-333.